Quantum licensee begins $5-million (U.S.) raise

Mr. John Duffy reports QUANTUM BIOPHARMA LICENSEE UNBUZZD WELLNESS INC. COMMENCES REG D CAPITAL RAISE CAMPAIGN TO FUND GROWTH AND POSSIBLE IPO Quantum Biopharma Ltd. licensee Unbuzzd Wellness Inc. has launched its previously announced Regulation D 506(c) offering to raise up to $5.0-million (U.S.) to finance growth and establish a path to a possible initial public offering. This will not impact or dilute Quantum Biopharma shareholders. Quantum Biopharma maintains an anti-dilution provision which ensures its ownership in Unbuzzd Wellness is 25 per cent until unbuzzd reaches $1-billion (U.S.) in valuation. Once Unbuzzd Wellness goes public, Quantum Biopharma will be able to access non-dilutive capital through its ownership. Unbuzzd has partnered with MZ Digital, a global leader in marketing, and Dealmaker, a leading on-line platform for raising capital to conduct the capital raise campaign. The Regulation D offering allows Unbuzzd to raise capital by selling and issuing securities to accredited investors without a cap on the amount raised. Investments can be made with traditional payments or with cryptocurrency payments: the latter through ALT5 Pay's digital payments platform. John Duffy, chief executive officer of Unbuzzd Wellness, stated: "This capital raise allows us to introduce investors to a new era in functional beverages aimed at supporting overall wellness after social occasions. Unbuzzd is a refreshing, science-backed beverage that helps people feel more refreshed and alert after drinking. This offering will help us raise the necessary capital to support direct-to-consumer, distributor and retail expansion plans." Mr. Duffy has over 20 years of leadership experience in the beverage industry, including as former vice-president of marketing assets and vice-president of national sales at Coca-Cola. Gerry David, board co-chair and former chief executive officer of Celsius Holdings with its best-selling energy drink Celsius Energy, added, "Together with our partners MZ Digital, a global leader in on-line marketing, and Dealmaker, a leading on-line platform for raising capital, we are excited to launch this offering to build our company and sales momentum, and position Unbuzzd for a future initial public offering." About Quantum Biopharma Ltd. Quantum Biopharma is a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development. Through its wholly owned subsidiary, Lucid Psycheceuticals Inc., Quantum Biopharma is focused on the research and development of its lead compound, Lucid-MS. Lucid-MS is a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. Quantum Biopharma invented Unbuzzd and spun out its OTC version to a company, Unbuzzd Wellness (formerly Celly Nutrition Corp.), led by industry veterans. Quantum Biopharma retains ownership of 20.11 per cent (as of March 31, 2025) of Unbuzzd Wellness. The agreement with Unbuzzd Wellness also includes royalty payments of 7 per cent of sales from Unbuzzd until payments to Quantum Biopharma total $250-million. Once $250-million is reached, the royalty drops to 3 per cent in perpetuity. Quantum Biopharma retains 100 per cent of the rights to develop similar products or alternative formulations specifically for pharmaceutical and medical uses. Quantum Biopharma maintains a portfolio of strategic investments through its wholly owned subsidiary, FSD Strategic Investments Inc., which represents loans secured by residential or commercial property. About Unbuzzd Wellness Inc. Unbuzzd Wellness, a non-trading but fully reporting public issuer, stands as a pioneering force in the wellness and recovery supplement landscape. Unbuzzd has been developed by a world-class R&D (research and development) team in pharmacology and medicine, with a commitment to innovation and quality. A proprietary blend of vitamins, minerals and herbs, Unbuzzd helps your body process alcohol faster, restore mental alertness and improve cognition so you can drink responsibly and drink refreshingly. Unbuzzd appeals to a broad target audience of alcohol consumers who want to have a good time, be in control and still feel great the next day. Scientifically backed by a recently completed double-blind, randomized, placebo-controlled crossover design clinical trial, Unbuzzd dramatically accelerates alcohol metabolism, speeds the reduction of blood alcohol concentration (BAC), restores mental clarity and reduces the symptoms of intoxication, impairment and hangover. We seek Safe Harbor.